Samsung Biologics Co Ltd Working Capital to Net Assets Ratio
Samsung Biologics Co Ltd working capital to net assets ratio. Samsung Biologics Co Ltd (207940) has a Working Capital to Net Assets ratio of 28.3% as of June 2026. Working capital of ₩2.36 Trillion (current assets of ₩5.33 Trillion minus current liabilities of ₩2.97 Trillion) is measured against net assets of ₩8.36 Trillion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Samsung Biologics Co Ltd to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Samsung Biologics Co Ltd (2014–2025)
Working capital to net assets ratio of Samsung Biologics Co Ltd from 2014 to 2025. This chart shows how Samsung Biologics Co Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 28.3%, reflecting working capital of ₩2.36 Trillion against net assets of ₩8.36 Trillion KRW. See 207940 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Samsung Biologics Co Ltd Working Capital to Net Assets Ratio by Year (2014–2025)
Samsung Biologics Co Ltd working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Samsung Biologics Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 207940 total asset value.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 25.2% | ₩1.88 Trillion | ₩7.45 Trillion | ₩4.41 Trillion | ₩2.53 Trillion | ▲ +9.9 pp |
| 2024 | 15.3% | ₩1.66 Trillion | ₩10.90 Trillion | ₩5.52 Trillion | ₩3.85 Trillion | ▲ +1.4 pp |
| 2023 | 13.9% | ₩1.36 Trillion | ₩9.83 Trillion | ₩5.52 Trillion | ₩4.16 Trillion | ▼ -11.5 pp |
| 2022 | 25.3% | ₩2.28 Trillion | ₩8.98 Trillion | ₩6.46 Trillion | ₩4.18 Trillion | ▼ -9.0 pp |
| 2021 | 34.4% | ₩1.72 Trillion | ₩4.99 Trillion | ₩2.82 Trillion | ₩1.11 Trillion | ▲ +9.1 pp |
| 2020 | 25.3% | ₩1.16 Trillion | ₩4.60 Trillion | ₩1.75 Trillion | ₩589.30 Billion | ▲ +10.0 pp |
| 2019 | 15.3% | ₩665.76 Billion | ₩4.35 Trillion | ₩1.36 Trillion | ₩690.51 Billion | ▼ -5.6 pp |
| 2018 | 20.9% | ₩867.15 Billion | ₩4.16 Trillion | ₩1.58 Trillion | ₩710.53 Billion | ▲ +62.8 pp |
| 2017 | -41.9% | ₩-1.67 Trillion | ₩3.98 Trillion | ₩621.00 Billion | ₩2.29 Trillion | ▼ -17.0 pp |
| 2016 | -24.9% | ₩-1.02 Trillion | ₩4.08 Trillion | ₩1.46 Trillion | ₩2.48 Trillion | ▲ +37.1 pp |
| 2015 | -61.9% | ₩-1.72 Trillion | ₩2.77 Trillion | ₩192.85 Billion | ₩1.91 Trillion | ▼ -58.8 pp |
| 2014 | -3.2% | ₩-19.96 Billion | ₩630.73 Billion | ₩216.84 Billion | ₩236.79 Billion | — |